A randomized, controlled trial of oral propranolol in infantile hemangioma. - Wikidata - awgldk - TriplyDB

A randomized, controlled trial of oral propranolol in infantile hemangioma.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

http://www.wikidata.org/entity/Q34668015

about

Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants Cardiovascular drugs in the treatment of infantile hemangioma Repurposing of approved cardiovascular drugs Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.Multifocal infantile haemangioma: a diagnostic challenge.Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model.Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.Treatment of infantile haemangiomas: recommendations of a European expert group.Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies.Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.Propranolol treatment for infantile hemangioma does not increase risk of childhood wheezing.Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma.Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study Somatic PIK3CA mutations as a driver of sporadic venous malformations.Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent When to stop propranolol for infantile hemangioma.Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway.Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.Infantile hemangioma status by dynamic infrared thermography: A preliminary study.PHACE syndrome--clinical features, aetiology and management.Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events - a review of the literature.The role of adaptive trial designs in drug development.Incidence, Treatment Patterns, and Health Care Costs of Infantile Hemangioma: Results of a Retrospective German Database Analysis.Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.Infant Colic

P2860

Q24187442-45A07223-BBBF-4198-9159-1CD2753C0038 Q26769978-2675FB36-6CED-43F2-8835-8A7EA6151BF7 Q28074453-CBE959CB-E7F2-4EC8-A2B6-C984B9F4FD00 Q33431654-F22EE4B8-7383-4FCD-A246-549584A743ED Q33433230-2754BA9F-B5AA-4B47-BB46-7F8D1C55B19C Q33577048-66EA0FD2-0AA9-4139-AF65-93EE9471B717 Q33685473-0A2F5F9B-1063-4486-8765-515FD92DF175 Q33767409-B66997B4-B8DB-4B56-8FF6-CFA0803A7B89 Q33802563-F2E44685-1AA0-4D5D-9B3F-441393F1E0BC Q33835368-64F47399-CF4A-4A91-B26C-5A902803272A Q34489319-807C1017-2162-48D7-A814-E4E3F7F343F0 Q35645474-6B44070C-280D-4DE9-BA23-82778D38841D Q35777099-AF693914-BC78-4FB6-AE8F-06110F8BF5CA Q36084905-83E5205A-A293-4379-B027-B16B719657BB Q36117648-51B55A50-BEE7-411F-87FE-798332358690 Q36195375-DC5B19ED-B5EB-49EF-B58A-4A01953A3DB6 Q36211734-FA413C01-6AAC-40BC-8E4E-66C604078BFE Q36278223-7DAB6002-2D39-4AFC-A404-194393793523 Q36299241-DBEA18F0-34D0-4F31-B51C-DC9E25AEB419 Q36362590-B006AF98-90FE-4C85-88B4-B1DDED71BB80 Q36440738-2492BB77-0172-4438-AC59-F2B1C12E8347 Q36512006-8B1B0600-1F03-4A87-A3FA-F24E665EC147 Q37130685-A71905DF-9E0F-420F-BAEF-F4BEC129C3A1 Q37205732-13DA8D84-A8C6-4269-B614-2436A49F635C Q37321874-8092BB8B-9643-4173-BB0A-F6B09BA09FEF Q37404693-1E1C1B56-27DD-4CEF-9A43-FE2660A179E1 Q37657969-DA32F41B-1160-4E65-811F-2E1421F5E40F Q37708790-9D2BC955-39AA-42FD-AFF3-28EB20CDDCE9 Q38373964-FDD5735E-F778-493E-93BC-6BAD6C2EFF5F Q38377887-D16DC010-EB60-455E-8A10-8D0B82AEF2B6 Q38380750-08D5527B-13F6-4FED-BA6D-2B3CEF75153D Q38393811-E13FB830-A75F-4995-A9FF-6F4EC1A740E9 Q38607717-A37CBE31-209E-49C9-9AA5-46D21E3A1E79 Q38662656-B8E2FA4E-21C9-47E2-A295-C9A06AA5474F Q38691922-18510B73-77EA-4AF6-AC6F-323BA6AFA806 Q38694569-2984B44D-3656-4947-8EA1-00B75E20B33A Q38766989-10132DD0-CBCC-44C1-AC2C-12FAA3B19F4F Q38769283-37C567FD-EC8A-4217-826B-DDCAEFB4F66A Q38772074-3C9BACC2-DEC9-4FFE-B5E5-E21CBFFA95D5 Q38789878-9A3A2372-9760-447C-89D1-29F6DD77F613

P2860

A randomized, controlled trial of oral propranolol in infantile hemangioma.

http://www.wikidata.org/entity/Q34668015

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@ast

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@en

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@nl

type

label

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@ast

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@en

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@nl

prefLabel

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@ast

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@en

A randomized, controlled trial of oral propranolol in infantile hemangioma.

@nl

P1433

Q34668015-3D1A4AA2-76D7-4026-A35B-85ECAD211F95

P1476

Q34668015-96C8FC90-DE05-464A-8473-8369DCE0D7C0

P2093

Q34668015-00FFF936-2A4A-4B93-A18F-C3256EB06809

Q34668015-082A3171-1150-4107-9D7E-2511ABF7466F

Q34668015-0D6A2543-79EC-4F7D-9D76-331869659B2B

Q34668015-0E853684-795C-491C-B53E-EEED480ED5D5

Q34668015-195849C5-3259-45A4-AF10-84AEA8D4DDFB

Q34668015-19601C66-A2A4-4875-903F-E09B5C2C5317

Q34668015-1C31538D-AECA-4A51-8447-0622E189AE32

Q34668015-1CEADC9C-F3D2-48D7-B9CB-112A2EE2C891

Q34668015-201C4D53-4511-420F-B113-6F6E94FC3F81

Q34668015-248B6726-8DEB-47B3-AA60-2E8A16E54A5D

P304

Q34668015-454FCBD1-F46A-463B-89D9-8E167426AF7E

P31

Q34668015-7154FA2F-6BAA-429E-9221-383C0603843E

P356

Q34668015-0F637891-B335-4C07-BD51-F1AC8057B0B0

P407

Q34668015-2E577F5D-8A4C-4D82-977C-62D20B69938C

P433

Q34668015-F748360C-01A9-43A1-AF17-72B0C650316E

P478

Q34668015-EE708402-A192-46FC-B36D-2A35582F66A4

P50

Q34668015-2869940B-EA28-4B20-A06D-2E4EA326D454

Q34668015-45D9882F-52B4-40F6-9301-C360C0EFCFFD

Q34668015-5F623FE0-8F3E-4EF7-908A-2D55828C91C2

Q34668015-C9A030DB-24F1-4FF0-8920-D2378008661D

Q34668015-CB6C4E87-0B2B-4CE8-B8F9-729DA63246B0

Q34668015-DD46A390-41A4-40FB-81A0-00DE80995022

P577

Q34668015-BDE73E2B-DF2E-4019-8F61-A14E88C5DE9A

P698

Q34668015-C6563780-E18E-4032-8772-9C9023E77BCD

P356

P1433

The New England Journal of Medicine

P1476

A randomized, controlled trial of oral propranolol in infantile hemangioma

@en

P2093

Adriana M Valencia

http://www.w3.org/2001/XMLSchema#string

Alain Delarue

http://www.w3.org/2001/XMLSchema#string

Alfons Krol

http://www.w3.org/2001/XMLSchema#string

Annabel Maruani

http://www.w3.org/2001/XMLSchema#string

Anthony J Mancini

http://www.w3.org/2001/XMLSchema#string

Antonio Torrelo

http://www.w3.org/2001/XMLSchema#string

Brandie Metz

http://www.w3.org/2001/XMLSchema#string

Caroline C Morgan

http://www.w3.org/2001/XMLSchema#string

Charles I Berul

http://www.w3.org/2001/XMLSchema#string

Christine Léauté-Labrèze

http://www.w3.org/2001/XMLSchema#string

P304

735-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1404710

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

Ilona J. Frieden

Sébastien Barbarot

Franck Boralevi

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25693013

http://www.w3.org/2001/XMLSchema#string